Page 90 - ESHRE2019

Summary
No indication to offer HBV and HCV positive patients modified ART treatment  Negative effect of HBV, HCV and HPV on all semen parameters
 Consider assessing DFI and elective use of ICSI (instead of IVF)
 HPV may be implicated in ART outcome and miscarriage risk
 ZIKV risk is an ongoing factor to assess in all ART patients
 Mode and frequency of viral screening should be reviewed
 No indication for a separate Laboratory to handle viral positive samples
Empowering the freedom of reproductive choice with wisdo
m
Bibliography 1
Epelboin S et al. Zika Virus and reproduction: facts, questions and current management. Human Reproduction Update 2017; 23(6):629‐654
Garolla A et al. Human Papilloma Prophylactic Vaccination improves reproductive outcome in infertile patients with HPV semen infection: a retrospective study. Sci Rep 2018; 8:912
Gilling‐Smith C & Vernazza P. Viral disease and assisted reproduction technology. Textbook of Assisted Reproductive techniques 2017 5th Ed Vol 2; 64:807‐819 Ed Gardner, Weissman, Howles, Sholam
Gold E et al. Screening for blood born viruses in assisted reproduction; is annual testing necessary? Arch Gynaecol Obstet 2019; 299(6)
Jindal et al Guidelines for risk reduction when handling gametes from infected patients seeking assisted reproductive technologies. Reprod Biomed Online 2016;33(2):121‐30
Empowering the freedom of reproductive choice with wisdo
m
88
85